ST elevation myocardial infarction thienopyridine therapy: Revision history

30 June 2010

• curprev 20:5220:52, 30 June 2010‎ C Michael Gibson talk contribs‎ 22,313 bytes +72‎ →‎Prasugrel in the Management of Primary PCI of Patients
• curprev 20:4720:47, 30 June 2010‎ C Michael Gibson talk contribs‎ 22,241 bytes +702‎ →‎Prasugrel in the Management of Primary PCI of Patients
• curprev 20:3120:31, 30 June 2010‎ C Michael Gibson talk contribs‎ 21,539 bytes +1‎ →‎Overview
• curprev 20:3020:30, 30 June 2010‎ C Michael Gibson talk contribs‎ 21,538 bytes −46‎ →‎Overview
• curprev 20:2320:23, 30 June 2010‎ C Michael Gibson talk contribs‎ 21,584 bytes +451‎ →‎Prasugrel in the Management of Primary PCI of Patients
• curprev 20:1320:13, 30 June 2010‎ C Michael Gibson talk contribs‎ 21,133 bytes +245‎ →‎Prasugrel in the Management of Primary PCI of Patients
• curprev 20:0920:09, 30 June 2010‎ C Michael Gibson talk contribs‎ 20,888 bytes +808‎ →‎Dosing of clopidogrel in STEMI
• curprev 20:0420:04, 30 June 2010‎ C Michael Gibson talk contribs‎ 20,080 bytes +213‎ →‎Side effects of thienopyridines
• curprev 19:4819:48, 30 June 2010‎ C Michael Gibson talk contribs‎ 19,867 bytes +2,762‎ →‎Primary PCI patients

8 December 2009

• curprev 16:3616:36, 8 December 2009‎ Smitakohli talk contribs‎ 17,105 bytes +178‎ No edit summary

19 November 2009

• curprev 21:0121:01, 19 November 2009‎ Smitakohli talk contribs‎ 16,927 bytes +78‎ No edit summary
• curprev 20:4420:44, 19 November 2009‎ Smitakohli talk contribs‎ 16,849 bytes +1,440‎ No edit summary

1 June 2009

• curprev 14:0514:05, 1 June 2009‎ Swilliams talk contribs‎ 15,409 bytes +151‎ No edit summary

29 May 2009

• curprev 14:0414:04, 29 May 2009‎ Swilliams talk contribs‎ 15,258 bytes 0‎ /* ACC/AHA Guidelines (DO NOT EDIT) {{cite journal |author=Antman EM, Hand M, Armstrong PW, et al |title=2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the Americ

28 May 2009

• curprev 20:1720:17, 28 May 2009‎ Swilliams talk contribs‎ 15,258 bytes −1,869‎ →‎Sources
• curprev 14:4714:47, 28 May 2009‎ Swilliams talk contribs‎ m 17,127 bytes 0‎ ST Elevation Myocardial Infarction Thienopyridine Therapy moved to ST elevation myocardial infarction thienopyridine therapy
• curprev 14:4614:46, 28 May 2009‎ Swilliams talk contribs‎ 17,127 bytes +3,081‎ →‎ACC / AHA Guidelines (DO NOT EDIT)

1 May 2009

• curprev 16:0916:09, 1 May 2009‎ Swilliams talk contribs‎ 14,046 bytes +1,870‎ No edit summary

16 February 2009

• curprev 14:5014:50, 16 February 2009‎ C Michael Gibson talk contribs‎ 12,176 bytes +506‎ →‎Primary PCI patients

15 February 2009

• curprev 21:2521:25, 15 February 2009‎ C Michael Gibson talk contribs‎ 11,670 bytes +2‎ →‎Reduction in mortality associated with clopidogrel administration in conjunction with fibrinolytic agents: Results of COMMIT
• curprev 21:2521:25, 15 February 2009‎ C Michael Gibson talk contribs‎ 11,668 bytes +2‎ →‎Generalizability of results from CLARITY
• curprev 21:2421:24, 15 February 2009‎ C Michael Gibson talk contribs‎ 11,666 bytes +2‎ →‎Safety of Clopidogrel in CLARITY
• curprev 21:2421:24, 15 February 2009‎ C Michael Gibson talk contribs‎ 11,664 bytes +91‎ →‎Angiographic efficacy of Clopidogrel as adjunctive therapy to fibrinolysis in STEMI patients
• curprev 21:2221:22, 15 February 2009‎ C Michael Gibson talk contribs‎ 11,573 bytes +98‎ →‎Overview
• curprev 21:1921:19, 15 February 2009‎ C Michael Gibson talk contribs‎ 11,475 bytes +857‎ →‎Overview
• curprev 21:0321:03, 15 February 2009‎ C Michael Gibson talk contribs‎ 10,618 bytes +118‎ →‎Primary PCI patients
• curprev 21:0021:00, 15 February 2009‎ C Michael Gibson talk contribs‎ 10,500 bytes +816‎ →‎Primary PCI patients
• curprev 20:4820:48, 15 February 2009‎ C Michael Gibson talk contribs‎ 9,684 bytes +250‎ →‎Primary PCI patients
• curprev 20:4620:46, 15 February 2009‎ C Michael Gibson talk contribs‎ 9,434 bytes +643‎ →‎Dosing of clopidogrel in STEMI
• curprev 20:3720:37, 15 February 2009‎ C Michael Gibson talk contribs‎ 8,791 bytes +145‎ →‎Dosing of clopidogrel
• curprev 20:3620:36, 15 February 2009‎ C Michael Gibson talk contribs‎ 8,646 bytes 0‎ →‎Reduction in mortality associated with clopidogrel administration in conjunction with fibrinolytic agents: Results of COMMIT
• curprev 20:3520:35, 15 February 2009‎ C Michael Gibson talk contribs‎ 8,646 bytes −502‎ →‎Reduction in mortality associated with clopidogrel administration in conjunction with fibrinolytic agents: Results of COMMIT
• curprev 20:2220:22, 15 February 2009‎ C Michael Gibson talk contribs‎ 9,148 bytes −59‎ →‎Reduction in mortality associated with clopidogrel administration in conjunction with fibrinolytic agents: Results of COMMIT
• curprev 19:5719:57, 15 February 2009‎ C Michael Gibson talk contribs‎ 9,207 bytes +1,873‎ →‎Reduction in mortality associated with clopidogrel
• curprev 19:2919:29, 15 February 2009‎ C Michael Gibson talk contribs‎ 7,334 bytes +685‎ →‎Generalizability of results from CLARITY
• curprev 19:2419:24, 15 February 2009‎ C Michael Gibson talk contribs‎ 6,649 bytes +71‎ →‎Clinical Trial Data
• curprev 19:2219:22, 15 February 2009‎ C Michael Gibson talk contribs‎ 6,578 bytes +10‎ →‎Guidelines (DO NOT EDIT)
• curprev 19:2119:21, 15 February 2009‎ C Michael Gibson talk contribs‎ 6,568 bytes +147‎ →‎Dosing
• curprev 19:2019:20, 15 February 2009‎ C Michael Gibson talk contribs‎ 6,421 bytes +19‎ →‎Side Effects
• curprev 19:1919:19, 15 February 2009‎ C Michael Gibson talk contribs‎ 6,402 bytes +83‎ →‎Clinical Trial Data
• curprev 19:1519:15, 15 February 2009‎ C Michael Gibson talk contribs‎ 6,319 bytes +7‎ →‎Clinical Trial Data
• curprev 19:0619:06, 15 February 2009‎ C Michael Gibson talk contribs‎ 6,312 bytes −1,411‎ →‎Clinical Trial Data
• curprev 18:5618:56, 15 February 2009‎ C Michael Gibson talk contribs‎ 7,723 bytes +1‎ →‎Overview
• curprev 18:2618:26, 15 February 2009‎ C Michael Gibson talk contribs‎ 7,722 bytes +205‎ →‎Mechanism of Benefit
• curprev 18:2318:23, 15 February 2009‎ C Michael Gibson talk contribs‎ 7,517 bytes +268‎ →‎Mechanism of Benefit
• curprev 18:1618:16, 15 February 2009‎ C Michael Gibson talk contribs‎ 7,249 bytes +24‎ →‎Side Effects
• curprev 18:1418:14, 15 February 2009‎ C Michael Gibson talk contribs‎ 7,225 bytes +1,356‎ →‎Clinical Trial Data
• curprev 18:1018:10, 15 February 2009‎ C Michael Gibson talk contribs‎ 5,869 bytes +4‎ →‎Mechanism of Benefit
• curprev 18:0818:08, 15 February 2009‎ C Michael Gibson talk contribs‎ 5,865 bytes +2,709‎ No edit summary

11 February 2009

• curprev 18:3018:30, 11 February 2009‎ C Michael Gibson talk contribs‎ 3,156 bytes +3,156‎ No edit summary